{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T14:24:03Z","timestamp":1794407043661,"version":"4.9.0"},"reference-count":89,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T00:00:00Z","timestamp":1699833600000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Psychiatry"],"published-print":{"date-parts":[[2023,9]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>We aimed to identify diagnosis-specific\/transdiagnostic\/transoutcome multivariable candidate predictors (MCPs) of key outcomes in mental disorders. We conducted\u00a0an umbrella review (protocol\u00a0<jats:ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/osf.io\/gpysa\/\">link<\/jats:ext-link>), searching MEDLINE\/Embase (19\/07\/2022), including systematic reviews of studies reporting on MCPs of response, remission, recovery, or relapse, in DSM\/ICD-defined mental disorders. From published predictors, we filtered MCPs, validating MCP criteria. AMSTAR2\/PROBAST measured quality\/risk of bias of systematic reviews\/individual studies. We included 117 systematic reviews, 403 studies, 299,888 individuals with mental disorders, testing 796 prediction models. Only 4.3%\/1.2% of the systematic reviews\/individual studies were at low risk of bias. The most frequently targeted outcome was remission (36.9%), the least frequent was recovery (2.5%). Studies mainly focused on depressive (39.4%), substance-use (17.9%), and schizophrenia-spectrum (11.9%) disorders. We identified numerous MCPs within disorders for response, remission and relapse, but none for recovery. Transdiagnostic MCPs of remission included lower disease-specific symptoms (disorders\u2009=\u20095), female sex\/higher education (disorders\u2009=\u20093), and\u00a0quality of life\/functioning (disorders\u2009=\u20092). Transdiagnostic MCPs of relapse included higher disease-specific symptoms (disorders\u2009=\u20095), higher depressive symptoms (disorders\u2009=\u20093), and younger age\/higher anxiety symptoms\/global illness severity\/ number of previous episodes\/negative life events (disorders\u2009=\u20092). Finally, positive trans-outcome MCPs for depression included less negative life events\/depressive symptoms (response, remission, less relapse), female sex (response, remission) and better functioning (response, less relapse); for schizophrenia, less positive symptoms\/higher depressive symptoms (remission, less relapse); for substance use disorder, marital status\/higher education (remission, less relapse). Male sex, younger age, more clinical symptoms and comorbid mental\/physical symptoms\/disorders were poor prognostic factors, while positive factors included social contacts and employment, absent negative life events, higher education, early access\/intervention, lower disease-specific and comorbid mental and physical symptoms\/conditions, across mental disorders. Current data limitations include high risk of bias of studies and extraction of single predictors from multivariable models. Identified MCPs can inform future development, validation or refinement of prediction models of key outcomes in mental disorders.<\/jats:p>","DOI":"10.1038\/s41380-023-02298-3","type":"journal-article","created":{"date-parts":[[2023,11,13]],"date-time":"2023-11-13T13:01:45Z","timestamp":1699880505000},"page":"3671-3687","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":79,"title":["An umbrella review of candidate predictors of response, remission, recovery, and relapse across mental disorders"],"prefix":"10.1038","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4877-7233","authenticated-orcid":false,"given":"Marco","family":"Solmi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuele","family":"Cortese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Vita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2032-1181","authenticated-orcid":false,"given":"Michele","family":"De Prisco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joaquim","family":"Radua","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9019-4125","authenticated-orcid":false,"given":"Elena","family":"Dragioti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole","family":"K\u00f6hler-Forsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanna M.","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Eudave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Aymerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Borja","family":"Pedruzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8554-3519","authenticated-orcid":false,"given":"Stella","family":"Rosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8530-5596","authenticated-orcid":false,"given":"Michel","family":"Sab\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5786-5203","authenticated-orcid":false,"given":"Mikkel","family":"Hojlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Catalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"de Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9647-0853","authenticated-orcid":false,"given":"Michele","family":"Fornaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Ostuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1073-9282","authenticated-orcid":false,"given":"Corrado","family":"Barbui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gonzalo","family":"Salazar-de-Pablo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3582-6788","authenticated-orcid":false,"given":"Paolo","family":"Fusar-Poli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph U.","family":"Correll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,13]]},"reference":[{"key":"2298_CR1","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/s41380-021-01161-7","volume":"27","author":"M Solmi","year":"2021","unstructured":"Solmi M, Radua J, Olivola M, Croce E, Soardo L, Salazar de Pablo G, et al. Age at onset of mental disorders worldwide: large-scale meta-analysis of 192 epidemiological studies. Mol Psychiatry. 2021;27:281\u201395.","journal-title":"Mol Psychiatry"},{"key":"2298_CR2","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/wps.20994","volume":"21","author":"CU Correll","year":"2022","unstructured":"Correll CU, Solmi M, Croatto G, Schneider LK, Rohani-Montez SC, Fairley L, et al. Mortality in people with schizophrenia: a systematic review and meta-analysis of relative risk and aggravating or attenuating factors. World Psychiatry. 2022;21:248\u201371.","journal-title":"World Psychiatry"},{"key":"2298_CR3","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1176\/appi.ajp.21121189","volume":"179","author":"M Solmi","year":"2022","unstructured":"Solmi M, Taipale H, Holm M, Tanskanen A, Mittendorfer-Rutz E, Correll CU, et al. Effectiveness of antipsychotic use for reducing risk of work disability: results from a within-subject analysis of a Swedish National Cohort of 21,551 patients with first-episode nonaffective psychosis. Am J Psychiatry. 2022;179:938\u201346.","journal-title":"Am J Psychiatry"},{"key":"2298_CR4","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1176\/appi.ajp.2017.16121358","volume":"174","author":"S Leucht","year":"2017","unstructured":"Leucht S, Leucht C, Huhn M, Chaimani A, Mavridis D, Helfer B, et al. Sixty years of placebo-controlled antipsychotic drug trials in acute schizophrenia: systematic review, bayesian meta-analysis, and meta-regression of efficacy predictors. Am J Psychiatry. 2017;174:927\u201342.","journal-title":"Am J Psychiatry"},{"key":"2298_CR5","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1093\/schbul\/sbs130","volume":"39","author":"E J\u00e4\u00e4skel\u00e4inen","year":"2013","unstructured":"J\u00e4\u00e4skel\u00e4inen E, Juola P, Hirvonen N, McGrath JJ, Saha S, Isohanni M, et al. A systematic review and meta-analysis of recovery in schizophrenia. Schizophr Bull. 2013;39:1296\u2013306.","journal-title":"Schizophr Bull"},{"key":"2298_CR6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.jad.2014.02.026","volume":"159","author":"P Cuijpers","year":"2014","unstructured":"Cuijpers P, Karyotaki E, Weitz E, Andersson G, Hollon SD, van Straten A. The effects of psychotherapies for major depression in adults on remission, recovery and improvement: a meta-analysis. J Affect Disord. 2014;159:118\u201326.","journal-title":"J Affect Disord"},{"key":"2298_CR7","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S2215-0366(17)30038-X","volume":"4","author":"R Gueorguieva","year":"2017","unstructured":"Gueorguieva R, Chekroud AM, Krystal JH. Trajectories of relapse in randomised, placebo-controlled trials of treatment discontinuation in major depressive disorder: an individual patient-level data meta-analysis. Lancet Psychiatry. 2017;4:230\u20137.","journal-title":"Lancet Psychiatry"},{"key":"2298_CR8","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/wps.20941","volume":"21","author":"F Leichsenring","year":"2022","unstructured":"Leichsenring F, Steinert C, Rabung S, Ioannidis JPA. The efficacy of psychotherapies and pharmacotherapies for mental disorders in adults: an umbrella review and meta-analytic evaluation of recent meta-analyses. World Psychiatry. 2022;21:133\u201345.","journal-title":"World Psychiatry"},{"key":"2298_CR9","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.drugalcdep.2016.08.625","volume":"168","author":"MJ Fleury","year":"2016","unstructured":"Fleury MJ, Djouini A, Hu\u1ef3nh C, Tremblay J, Ferland F, M\u00e9nard JM, et al. Remission from substance use disorders: a systematic review and meta-analysis. Drug Alcohol Depend. 2016;168:293\u2013306.","journal-title":"Drug Alcohol Depend"},{"key":"2298_CR10","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1038\/s41380-022-01528-4","volume":"27","author":"AJ Meehan","year":"2022","unstructured":"Meehan AJ, Lewis SJ, Fazel S, Fusar-Poli P, Steyerberg EW, Stahl D, et al. Clinical prediction models in psychiatry: a systematic review of two decades of progress and challenges. Mol Psychiatry. 2022;27:2700\u20138.","journal-title":"Mol Psychiatry"},{"key":"2298_CR11","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/S1470-2045(20)30061-9","volume":"21","author":"JA Ledermann","year":"2020","unstructured":"Ledermann JA, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, et al. Rucaparib for patients with platinum-sensitive, recurrent ovarian carcinoma (ARIEL3): post-progression outcomes and updated safety results from a randomised, placebo-controlled, phase 3 trial. Lancet Oncol. 2020;21:710\u201322.","journal-title":"Lancet Oncol"},{"key":"2298_CR12","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jamapsychiatry.2018.2530","volume":"75","author":"P Fusar-Poli","year":"2018","unstructured":"Fusar-Poli P, Hijazi Z, Stahl D, Steyerberg EW. The science of prognosis in psychiatry: a review. JAMA Psychiatry. 2018;75:1289\u201397.","journal-title":"JAMA Psychiatry"},{"key":"2298_CR13","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1093\/schbul\/sbaa120","volume":"47","author":"G Salazar de Pablo","year":"2021","unstructured":"Salazar de Pablo G, Studerus E, Vaquerizo-Serrano J, Irving J, Catalan A, Oliver D, et al. Implementing precision psychiatry: a systematic review of individualized prediction models for clinical practice. Schizophr Bull. 2021;47:284\u201397.","journal-title":"Schizophr Bull"},{"key":"2298_CR14","doi-asserted-by":"crossref","first-page":"e070849","DOI":"10.1136\/bmj-2022-070849","volume":"378","author":"M Gates","year":"2022","unstructured":"Gates M, Gates A, Pieper D, Fernandes RM, Tricco AC, Moher D, et al. Reporting guideline for overviews of reviews of healthcare interventions: development of the PRIOR statement. BMJ. 2022;378:e070849.","journal-title":"BMJ."},{"key":"2298_CR15","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/jamapsychiatry.2021.3452","volume":"79","author":"M H\u00f8jlund","year":"2022","unstructured":"H\u00f8jlund M, Haddad PM, Correll CU. Limitations in research on maintenance treatment for individuals with schizophrenia. JAMA Psychiatry. 2022;79:85\u20136.","journal-title":"JAMA Psychiatry"},{"key":"2298_CR16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/S2215-0366(21)00078-X","volume":"8","author":"M H\u00f8jlund","year":"2021","unstructured":"H\u00f8jlund M, Kemp AF, Haddad PM, Neill JC, Correll CU. Standard versus reduced dose of antipsychotics for relapse prevention in multi-episode schizophrenia: a systematic review and meta-analysis of randomised controlled trials. Lancet Psychiatry. 2021;8:471\u201386.","journal-title":"Lancet Psychiatry"},{"key":"2298_CR17","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1093\/schbul\/sbac039","volume":"48","author":"H Taipale","year":"2022","unstructured":"Taipale H, Tanskanen A, Luykx JJ, Solmi M, Leucht S, Correll CU, et al. Optimal doses of specific antipsychotics for relapse prevention in a nationwide cohort of patients with schizophrenia. Schizophr Bull. 2022;48:774\u201384.","journal-title":"Schizophr Bull"},{"key":"2298_CR18","doi-asserted-by":"crossref","first-page":"45463","DOI":"10.4088\/JCP.22r14490","volume":"84","author":"M Sab\u00e9","year":"2023","unstructured":"Sab\u00e9 M, Pallis K, Solmi M, Crippa A, Sentissi O, Kaiser S. Comparative effects of 11 antipsychotics on weight gain and metabolic function in patients with acute schizophrenia: a dose-response meta-analysis. J Clin Psychiatry. 2023;84:45463.","journal-title":"J Clin Psychiatry"},{"key":"2298_CR19","doi-asserted-by":"crossref","first-page":"B16","DOI":"10.1016\/j.clinthera.2011.11.016","volume":"33","author":"CU Correll","year":"2011","unstructured":"Correll CU, Kishimoto T, Nielsen J, Kane JM. Quantifying clinical relevance in the treatment of schizophrenia. Clin Ther. 2011;33:B16\u201339.","journal-title":"Clin Ther"},{"key":"2298_CR20","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.schres.2007.09.006","volume":"98","author":"SZ Levine","year":"2008","unstructured":"Levine SZ, Rabinowitz J, Engel R, Etschel E, Leucht S. Extrapolation between measures of symptom severity and change: an examination of the PANSS and CGI. Schizophr Res. 2008;98:318\u201322.","journal-title":"Schizophr Res"},{"key":"2298_CR21","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1176\/appi.ajp.162.3.441","volume":"162","author":"NC Andreasen","year":"2005","unstructured":"Andreasen NC, Carpenter WT, Kane JM, Lasser RA, Marder SR, Weinberger DR. Remission in schizophrenia: proposed criteria and rationale for consensus. Am J Psychiatry. 2005;162:441\u20139.","journal-title":"Am J Psychiatry"},{"key":"2298_CR22","doi-asserted-by":"crossref","first-page":"4008","DOI":"10.1136\/bmj.j4008","volume":"358","author":"BJ Shea","year":"2017","unstructured":"Shea BJ, Reeves BC, Wells G, Thuku M, Hamel C, Moran J, et al. AMSTAR 2: a critical appraisal tool for systematic reviews that include randomised or non-randomised studies of healthcare interventions, or both. BMJ. 2017;358:4008.","journal-title":"BMJ"},{"key":"2298_CR23","doi-asserted-by":"crossref","first-page":"51","DOI":"10.7326\/M18-1376","volume":"170","author":"R Wolff","year":"2019","unstructured":"Wolff R, Moons K, Riley R, Whiting P, Westwood M, Collins G, et al. PROBAST: a tool to assess the risk of bias and applicability of prediction model studies. Ann Intern Med. 2019;170:51\u20138.","journal-title":"Ann Intern Med"},{"key":"2298_CR24","doi-asserted-by":"crossref","unstructured":"Hyer MM, Phillips LL, Neigh GN. Sex differences in synaptic plasticity: hormones and beyond. Front Mol Neurosci. 2018;11:266.","DOI":"10.3389\/fnmol.2018.00266"},{"key":"2298_CR25","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/nri.2016.90","volume":"16","author":"SL Klein","year":"2016","unstructured":"Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol. 2016;16:626\u201338.","journal-title":"Nat Rev Immunol"},{"key":"2298_CR26","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1210\/er.2016-1007","volume":"37","author":"A Villa","year":"2016","unstructured":"Villa A, Vegeto E, Poletti A, Maggi A. Estrogens, neuroinflammation, and neurodegeneration. Endocr Rev. 2016;37:372\u2013402.","journal-title":"Endocr Rev"},{"key":"2298_CR27","doi-asserted-by":"crossref","DOI":"10.1186\/s12974-017-0920-8","volume":"14","author":"CA Mangold","year":"2017","unstructured":"Mangold CA, Wronowski B, Du M, Masser DR, Hadad N, Bixler GV, et al. Sexually divergent induction of microglial-associated neuroinflammation with hippocampal aging. J Neuroinflamm. 2017;14:141.","journal-title":"J Neuroinflamm"},{"key":"2298_CR28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.bbi.2021.07.014","volume":"97","author":"M Solmi","year":"2021","unstructured":"Solmi M, Suresh Sharma M, Osimo EF, Fornaro M, Bortolato B, Croatto G, et al. Peripheral levels of C-reactive protein, tumor necrosis factor-\u03b1, interleukin-6, and interleukin-1\u03b2 across the mood spectrum in bipolar disorder: a meta-analysis of mean differences and variability. Brain Behav Immun. 2021;97:193\u2013203.","journal-title":"Brain Behav Immun"},{"key":"2298_CR29","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/schbul\/sby160","volume":"45","author":"T Pillinger","year":"2019","unstructured":"Pillinger T, Osimo EF, Brugger S, Mondelli V, McCutcheon RA, Howes OD. A meta-analysis of immune parameters, variability, and assessment of modal distribution in psychosis and test of the immune subgroup hypothesis. Schizophr Bull. 2019;45:1120\u201333.","journal-title":"Schizophr Bull"},{"key":"2298_CR30","doi-asserted-by":"crossref","first-page":"eaaz5677","DOI":"10.1126\/scitranslmed.aaz5677","volume":"12","author":"EJ Davis","year":"2020","unstructured":"Davis EJ, Broestl L, Abdulai-Saiku S, Worden K, Bonham LW, Mi\u00f1ones-Moyano E, et al. A second X chromosome contributes to resilience in a mouse model of Alzheimer\u2019s disease. Sci Transl Med. 2020;12:eaaz5677.","journal-title":"Sci Transl Med"},{"key":"2298_CR31","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1016\/j.neubiorev.2014.09.001","volume":"46","author":"L Christov-Moore","year":"2014","unstructured":"Christov-Moore L, Simpson EA, Coud\u00e9 G, Grigaityte K, Iacoboni M, Ferrari PF. Empathy: gender effects in brain and behavior. Neurosci Biobehav Rev. 2014;46:604\u201327.","journal-title":"Neurosci Biobehav Rev"},{"key":"2298_CR32","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1001\/jamapsychiatry.2018.0623","volume":"75","author":"CU Correll","year":"2018","unstructured":"Correll CU, Galling B, Pawar A, Krivko A, Bonetto C, Ruggeri M, et al. Comparison of early intervention services vs treatment as usual for early-phase psychosis: a systematic review, meta-analysis, and meta-regression. JAMA Psychiatry Am Med Assoc. 2018;75:555\u201365.","journal-title":"JAMA Psychiatry Am Med Assoc"},{"key":"2298_CR33","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/s41380-022-01727-z","volume":"28","author":"M Solmi","year":"2023","unstructured":"Solmi M, Croatto G, Piva G, Rosson S, Fusar-Poli P, Rubio JM, et al. Efficacy and acceptability of psychosocial interventions in schizophrenia: systematic overview and quality appraisal of the meta-analytic evidence. Mol Psychiatry. 2023;28:354\u201368.","journal-title":"Mol Psychiatry"},{"key":"2298_CR34","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/j.jad.2021.07.101","volume":"294","author":"G Salazar de Pablo","year":"2021","unstructured":"Salazar de Pablo G, Solmi M, Vaquerizo-Serrano J, Radua J, Passina A, Morsillo P, et al. Primary prevention of depression: an umbrella review of controlled interventions. J Affect Disord. 2021;294:957\u201370.","journal-title":"J Affect Disord"},{"key":"2298_CR35","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1097\/HRP.0000000000000294","volume":"29","author":"G Salazar De Pablo","year":"2021","unstructured":"Salazar De Pablo G, De Micheli A, Solmi M, Oliver D, Catalan A, Verdino V, et al. Universal and selective interventions to prevent poor mental health outcomes in young people: systematic review and meta-analysis. Harv Rev Psychiatry. 2021;29:196\u2013215.","journal-title":"Harv Rev Psychiatry"},{"key":"2298_CR36","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1002\/wps.20869","volume":"20","author":"P Fusar-Poli","year":"2021","unstructured":"Fusar-Poli P, Correll C, Arango C, Berk M, Patel V, Ioannidis J. Preventive psychiatry: a blueprint for improving the mental health of young people. World Psychiatry. 2021;20:200\u201321.","journal-title":"World Psychiatry"},{"key":"2298_CR37","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/da.22250","volume":"31","author":"K Wolitzky-Taylor","year":"2014","unstructured":"Wolitzky-Taylor K, Dour H, Zinbarg R, Mineka S, Vrshek-Schallhorn S, Epstein A, et al. Experiencing core symptoms of anxiety and unipolar mood disorders in late adolescence predicts disorder onset in early adulthood. Depress Anxiety. 2014;31:207\u201313.","journal-title":"Depress Anxiety"},{"key":"2298_CR38","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.jpsychires.2018.05.020","volume":"103","author":"CA K\u00f6hler","year":"2018","unstructured":"K\u00f6hler CA, Evangelou E, Stubbs B, Solmi M, Veronese N, Belbasis L, et al. Mapping risk factors for depression across the lifespan: an umbrella review of evidence from meta-analyses and Mendelian randomization studies. J Psychiatr Res. 2018;103:189\u2013207.","journal-title":"J Psychiatr Res"},{"key":"2298_CR39","doi-asserted-by":"crossref","DOI":"10.1186\/s12916-021-02040-2","volume":"19","author":"C Ding","year":"2021","unstructured":"Ding C, O\u2019Neill D, Bell S, Stamatakis E, Britton A. Association of alcohol consumption with morbidity and mortality in patients with cardiovascular disease: original data and meta-analysis of 48,423 men and women. BMC Med. 2021;19:167.","journal-title":"BMC Med"},{"key":"2298_CR40","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.drugalcdep.2015.08.034","volume":"156","author":"E Silins","year":"2015","unstructured":"Silins E, Fergusson DM, Patton GC, Horwood LJ, Olsson CA, Hutchinson DM, et al. Adolescent substance use and educational attainment: an integrative data analysis comparing cannabis and alcohol from three Australasian cohorts. Drug Alcohol Depend. 2015;156:90\u20136.","journal-title":"Drug Alcohol Depend"},{"key":"2298_CR41","doi-asserted-by":"crossref","first-page":"2214","DOI":"10.1001\/jama.2016.17324","volume":"316","author":"LS Rotenstein","year":"2016","unstructured":"Rotenstein LS, Ramos MA, Torre M, Segal JB, Peluso MJ, Guille C, et al. Prevalence of depression, depressive symptoms, and suicidal ideation among medical students: a systematic review and meta-analysis. JAMA. 2016;316:2214\u201336.","journal-title":"JAMA."},{"key":"2298_CR42","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00406-022-01549-8","volume":"273","author":"HJ M\u00f6ller","year":"2023","unstructured":"M\u00f6ller HJ, Falkai P. Is the serotonin hypothesis\/theory of depression still relevant? Methodological reflections motivated by a recently published umbrella review. Eur Arch Psychiatry Clin Neurosci 2023;273:1\u20133.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2298_CR43","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/j.jad.2010.12.016","volume":"131","author":"KM Holma","year":"2011","unstructured":"Holma KM, Melartin TK, Holma IAK, Paunio T, Isomets\u00e4 ET. Family history of psychiatric disorders and the outcome of psychiatric patients with DSM-IV major depressive disorder. J Affect Disord. 2011;131:251\u20139.","journal-title":"J Affect Disord"},{"key":"2298_CR44","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1016\/j.psychres.2013.09.027","volume":"210","author":"C Faravelli","year":"2013","unstructured":"Faravelli C, Alessandra Scarpato M, Castellini G, Lo, Sauro C. Gender differences in depression and anxiety: the role of age. Psychiatry Res. 2013;210:1301\u20133.","journal-title":"Psychiatry Res"},{"key":"2298_CR45","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","volume":"9","author":"GBD Collaborators Mental Disorders.","year":"2022","unstructured":"GBD Collaborators Mental Disorders. Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet Psychiatry. 2022;9:137\u201350.","journal-title":"Lancet Psychiatry."},{"key":"2298_CR46","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.biopsych.2019.04.028","volume":"86","author":"GE Hodes","year":"2019","unstructured":"Hodes GE, Epperson CN. Sex differences in vulnerability and resilience to stress across the life span. Biol Psychiatry. 2019;86:421\u201332.","journal-title":"Biol Psychiatry"},{"key":"2298_CR47","doi-asserted-by":"crossref","unstructured":"Abbafati C, Abbas KM, Abbasi-Kangevari M, Abd-Allah F, Abdelalim A, Abdollahi M, et al. Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019. Lancet. 2020;396:1204\u201322.","DOI":"10.1016\/S0140-6736(20)30925-9"},{"key":"2298_CR48","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/acps.12526","volume":"133","author":"SD \u00d8stergaard","year":"2016","unstructured":"\u00d8stergaard SD, Lemming OM, Mors O, Correll CU, Bech P. PANSS-6: a brief rating scale for the measurement of severity in schizophrenia. Acta Psychiatr Scand. 2016;133:436\u201344.","journal-title":"Acta Psychiatr Scand"},{"key":"2298_CR49","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","volume":"16","author":"K Kroenke","year":"2001","unstructured":"Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16:606\u201313.","journal-title":"J Gen Intern Med"},{"key":"2298_CR50","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/archinte.166.10.1092","volume":"166","author":"RL Spitzer","year":"2006","unstructured":"Spitzer RL, Kroenke K, Williams JBW, L\u00f6we B. A brief measure for assessing generalized anxiety disorder: the GAD-7. Arch Intern Med. 2006;166:1092\u20137.","journal-title":"Arch Intern Med"},{"key":"2298_CR51","doi-asserted-by":"crossref","first-page":"2606","DOI":"10.1017\/S0033291720004584","volume":"52","author":"S Kinoshita","year":"2022","unstructured":"Kinoshita S, Cortright K, Crawford A, Mizuno Y, Yoshida K, Hilty D, et al. Changes in telepsychiatry regulations during the COVID-19 pandemic: 17 countries and regions\u2019 approaches to an evolving healthcare landscape. Psychol Med. 2022;52:2606\u201313.","journal-title":"Psychol Med"},{"key":"2298_CR52","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.euroneuro.2022.06.004","volume":"61","author":"G Menculini","year":"2022","unstructured":"Menculini G, Verdolini N, Gobbicchi C, Del Bello V, Serra R, Brustenghi F, et al. Clinical and psychopathological correlates of duration of untreated illness (DUI) in affective spectrum disorders. Eur Neuropsychopharmacol. 2022;61:60\u201370.","journal-title":"Eur Neuropsychopharmacol"},{"key":"2298_CR53","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1007\/s00406-017-0811-0","volume":"268","author":"A Murru","year":"2018","unstructured":"Murru A, Pacchiarotti I, Verdolini N, Reinares M, Torrent C, Geoffroy PA, et al. Modifiable and non-modifiable factors associated with functional impairment during the inter-episodic periods of bipolar disorder. Eur Arch Psychiatry Clin Neurosci. 2018;268:749\u201355.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2298_CR54","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.mcna.2022.04.002","volume":"107","author":"K Nikolitch","year":"2023","unstructured":"Nikolitch K, Saraf G, Solmi M, Kroenke K, Fiedorowicz JG. Fire and darkness: on the assessment and management of bipolar disorder. Med Clin North Am. 2023 ;107:31\u201360.","journal-title":"Med Clin North Am"},{"key":"2298_CR55","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1111\/bdi.12609","volume":"20","author":"LN Yatham","year":"2018","unstructured":"Yatham LN, Kennedy SH, Parikh SV, Schaffer A, Bond DJ, Frey BN, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) 2018 guidelines for the management of patients with bipolar disorder. Bipolar Disord. 2018;20:97\u2013170.","journal-title":"Bipolar Disord"},{"key":"2298_CR56","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/wps.20997","volume":"21","author":"R McIntyre","year":"2022","unstructured":"McIntyre R, Alda M, Baldessarini R, Bauer M, Berk M, Correll C, et al. The clinical characterization of the adult patient with bipolar disorder aimed at personalization of management. World Psychiatry. 2022;21:364\u201387.","journal-title":"World Psychiatry"},{"key":"2298_CR57","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1016\/j.jad.2013.08.028","volume":"151","author":"R Belzeaux","year":"2013","unstructured":"Belzeaux R, Correard N, Boyer L, Etain B, Loftus J, Bellivier F, et al. Depressive residual symptoms are associated with lower adherence to medication in bipolar patients without substance use disorder: Results from the FACE-BD cohort. J Affect Disord. 2013;151:1009\u201315.","journal-title":"J Affect Disord"},{"key":"2298_CR58","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/j.jad.2020.01.141","volume":"266","author":"GE Hunt","year":"2020","unstructured":"Hunt GE, Malhi GS, Lai HMX, Cleary M. Prevalence of comorbid substance use in major depressive disorder in community and clinical settings, 1990\u20132019: Systematic review and meta-analysis. J Affect Disord. 2020;266:288\u2013304.","journal-title":"J Affect Disord"},{"key":"2298_CR59","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/add.15735","volume":"117","author":"JA Puddephatt","year":"2022","unstructured":"Puddephatt JA, Irizar P, Jones A, Gage SH, Goodwin L. Associations of common mental disorder with alcohol use in the adult general population: a systematic review and meta-analysis. Addiction. 2022;117:1543\u201372.","journal-title":"Addiction."},{"key":"2298_CR60","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/wps.20771","volume":"19","author":"M Maj","year":"2020","unstructured":"Maj M, Stein DJ, Parker G, Zimmerman M, Fava GA, De Hert M, et al. The clinical characterization of the adult patient with depression aimed at personalization of management. World Psychiatry. 2020;19:269\u201393.","journal-title":"World Psychiatry"},{"key":"2298_CR61","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/wps.20881","volume":"20","author":"CU Correll","year":"2021","unstructured":"Correll CU, Cortese S, Croatto G, Monaco F, Krinitski D, Arrondo G, et al. Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. World Psychiatry. 2021;20:244\u201375.","journal-title":"World Psychiatry"},{"key":"2298_CR62","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/wps.20860","volume":"20","author":"P Cuijpers","year":"2021","unstructured":"Cuijpers P, Quero S, Noma H, Ciharova M, Miguel C, Karyotaki E, et al. Psychotherapies for depression: a network meta-analysis covering efficacy, acceptability and long-term outcomes of all main treatment types. World Psychiatry. 2021;20:283\u201393.","journal-title":"World Psychiatry"},{"key":"2298_CR63","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/j.neubiorev.2020.09.002","volume":"120","author":"M Solmi","year":"2021","unstructured":"Solmi M, Dragioti E, Arango C, Radua J, Ostinelli E, Kilic O, et al. Risk and protective factors for mental disorders with onset in childhood\/adolescence: an umbrella review of published meta-analyses of observational longitudinal studies. Neurosci Biobehav Rev. 2021;120:565\u201373.","journal-title":"Neurosci Biobehav Rev"},{"key":"2298_CR64","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.neubiorev.2020.11.010","volume":"121","author":"M Solmi","year":"2021","unstructured":"Solmi M, Civardi S, Corti R, Anil J, Demurtas J, Lange S, et al. Risk and protective factors for alcohol and tobacco related disorders: An umbrella review of observational studies. Neurosci Biobehav Rev. 2021;121:20\u20138.","journal-title":"Neurosci Biobehav Rev"},{"key":"2298_CR65","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1192\/bjp.2021.222","volume":"221","author":"C Gastaldon","year":"2022","unstructured":"Gastaldon C, Solmi M, Correll CU, Barbui C, Schoretsanitis G. Risk factors of postpartum depression and depressive symptoms: Umbrella review of current evidence from systematic reviews and meta-analyses of observational studies. Br J Psychiatry. 2022;221:591\u2013602.","journal-title":"Br J Psychiatry"},{"key":"2298_CR66","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.neubiorev.2021.03.014","volume":"126","author":"M Solmi","year":"2021","unstructured":"Solmi M, Dragioti E, Croatto G, Radua J, Borgwardt S, Carvalho AF, et al. Risk and protective factors for cannabis, cocaine, and opioid use disorders: An umbrella review of meta-analyses of observational studies. Neurosci Biobehav Rev. 2021;126:243\u201351.","journal-title":"Neurosci Biobehav Rev"},{"key":"2298_CR67","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1590\/1516-4446-2020-1099","volume":"43","author":"M Solmi","year":"2021","unstructured":"Solmi M, Radua J, Stubbs B, Ricca V, Moretti D, Busatta D, et al. Risk factors for eating disorders: an umbrella review of published meta-analyses. Braz J Psychiatry. 2021;43:314\u201323.","journal-title":"Braz J Psychiatry"},{"key":"2298_CR68","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1002\/wps.20894","volume":"20","author":"C Arango","year":"2021","unstructured":"Arango C, Dragioti E, Solmi M, Cortese S, Domschke K, Murray RM, et al. Risk and protective factors for mental disorders beyond genetics: an evidence-based atlas. World Psychiatry. 2021;20:417\u201336.","journal-title":"World Psychiatry"},{"key":"2298_CR69","doi-asserted-by":"crossref","first-page":"679379","DOI":"10.3389\/fpsyt.2021.679379","volume":"12","author":"M Solmi","year":"2021","unstructured":"Solmi M, Dragioti E, Croatto G, Radua J, Borgwardt S, Carvalho AF, et al. Risk and protective factors for personality disorders: an umbrella review of published meta-analyses of case-control and cohort studies. Front Psychiatry. 2021;12:679379.","journal-title":"Front Psychiatry"},{"key":"2298_CR70","doi-asserted-by":"crossref","unstructured":"Radua J, Ramella-Cravaro V, Ioannidis JPA, Reichenberg A, Phiphopthatsanee N, Amir T, et al. What causes psychosis? An umbrella review of risk and protective factors. Vol. 17, World Psychiatry. Blackwell Publishing Ltd; 2018. p 49\u201366.","DOI":"10.1002\/wps.20490"},{"key":"2298_CR71","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1111\/acps.12847","volume":"137","author":"L Belbasis","year":"2018","unstructured":"Belbasis L, K\u00f6hler CA, Stefanis N, Stubbs B, van Os J, Vieta E, et al. Risk factors and peripheral biomarkers for schizophrenia spectrum disorders: an umbrella review of meta-analyses. Acta Psychiatr Scand. 2018;137:88\u201397.","journal-title":"Acta Psychiatr Scand"},{"key":"2298_CR72","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.jaac.2017.07.780","volume":"56","author":"J Dray","year":"2017","unstructured":"Dray J, Bowman J, Campbell E, Freund M, Wolfenden L, Hodder RK, et al. Systematic review of universal resilience-focused interventions targeting child and adolescent mental health in the school setting. J Am Acad Child Adolesc Psychiatry. 2017;56:813\u201324.","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"2298_CR73","doi-asserted-by":"crossref","first-page":"e017858","DOI":"10.1136\/bmjopen-2017-017858","volume":"8","author":"S Joyce","year":"2018","unstructured":"Joyce S, Shand F, Tighe J, Laurent SJ, Bryant RA, Harvey SB. Road to resilience: a systematic review and meta-analysis of resilience training programmes and interventions. BMJ Open. 2018;8:e017858.","journal-title":"BMJ Open"},{"key":"2298_CR74","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1176\/appi.ajp.2021.21010031","volume":"178","author":"M Solmi","year":"2021","unstructured":"Solmi M, Fiedorowicz J, Poddighe L, Delogu M, Miola A, H\u00f8ye A, et al. Disparities in screening and treatment of cardiovascular diseases in patients with mental disorders across the world: systematic review and meta-analysis of 47 observational studies. Am J Psychiatry. 2021;178:793\u2013803.","journal-title":"Am J Psychiatry"},{"key":"2298_CR75","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jad.2020.03.075","volume":"271","author":"M Solmi","year":"2020","unstructured":"Solmi M, Veronese N, Galvano D, Favaro A, Ostinelli EG, Noventa V, et al. Factors associated with loneliness: an umbrella review of observational studies. J Affect Disord. 2020;271:131\u20138.","journal-title":"J Affect Disord"},{"key":"2298_CR76","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0920-9964(01)00375-9","volume":"58","author":"P Oosthuizen","year":"2002","unstructured":"Oosthuizen P, Emsley RA, Roberts MC, Turner J, Keyter L, Keyter N, et al. Depressive symptoms at baseline predict fewer negative symptoms at follow-up in patients with first-episode schizophrenia. Schizophr Res. 2002;58:247\u201352.","journal-title":"Schizophr Res"},{"key":"2298_CR77","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/acps.12135","volume":"129","author":"C Nordon","year":"2014","unstructured":"Nordon C, Rouillon F, Azorin JM, Barry C, Urbach M, Falissard B. Trajectories of antipsychotic response in drug-naive schizophrenia patients: results from the 6-month ESPASS follow-up study. Acta Psychiatr Scand. 2014;129:116\u201325.","journal-title":"Acta Psychiatr Scand"},{"key":"2298_CR78","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.schres.2015.07.021","volume":"168","author":"SF Austin","year":"2015","unstructured":"Austin SF, Mors O, Budtz-J\u00f8rgensen E, Secher RG, Hjorth\u00f8j CR, Bertelsen M, et al. Long-term trajectories of positive and negative symptoms in first episode psychosis: a 10 year follow-up study in the OPUS cohort. Schizophr Res. 2015;168:84\u201391.","journal-title":"Schizophr Res"},{"key":"2298_CR79","doi-asserted-by":"crossref","first-page":"e0187141","DOI":"10.1371\/journal.pone.0187141","volume":"12","author":"E Abdin","year":"2017","unstructured":"Abdin E, Chong SA, Vaingankar JA, Peh CX, Poon LY, Rao S, et al. Trajectories of positive, negative and general psychopathology symptoms in first episode psychosis and their relationship with functioning over a 2-year follow-up period. PLoS One. 2017;12:e0187141.","journal-title":"PLoS One"},{"key":"2298_CR80","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1093\/schbul\/sbaa153","volume":"47","author":"D Etchecopar-Etchart","year":"2021","unstructured":"Etchecopar-Etchart D, Korchia T, Loundou A, Llorca PM, Auquier P, Lan\u00e7on C, et al. Comorbid major depressive disorder in schizophrenia: a systematic review and meta-analysis. Schizophr Bull. 2021;47:298\u2013308.","journal-title":"Schizophr Bull"},{"key":"2298_CR81","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1016\/S0140-6736(21)01997-8","volume":"399","author":"J Schneider-Thoma","year":"2022","unstructured":"Schneider-Thoma J, Chalkou K, D\u00f6rries C, Bighelli I, Ceraso A, Huhn M, et al. Comparative efficacy and tolerability of 32 oral and long-acting injectable antipsychotics for the maintenance treatment of adults with schizophrenia: a systematic review and network meta-analysis. Lancet. 2022;399:824\u201336.","journal-title":"Lancet"},{"key":"2298_CR82","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1038\/s41380-022-01524-8","volume":"27","author":"J Hyde","year":"2022","unstructured":"Hyde J, Carr H, Kelley N, Seneviratne R, Reed C, Parlatini V, et al. Efficacy of neurostimulation across mental disorders: systematic review and meta-analysis of 208 randomized controlled trials. Mol Psychiatry. 2022;27:2709\u201319.","journal-title":"Mol Psychiatry"},{"key":"2298_CR83","doi-asserted-by":"crossref","unstructured":"Rosson S, de Filippis R, Croatto G, Collantoni E, Pallottino S, Guinart D, et al. Brain stimulation and other biological non-pharmacological interventions in mental disorders: an umbrella review. Neurosci Biobehav Rev. 2022;139:104743.","DOI":"10.1016\/j.neubiorev.2022.104743"},{"key":"2298_CR84","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/acps.12854","volume":"137","author":"B Galling","year":"2018","unstructured":"Galling B, Vernon JA, Pagsberg AK, Wadhwa A, Grudnikoff E, Seidman AJ, et al. Efficacy and safety of antidepressant augmentation of continued antipsychotic treatment in patients with schizophrenia. Acta Psychiatr Scand. 2018;137:187\u2013205.","journal-title":"Acta Psychiatr Scand"},{"key":"2298_CR85","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1017\/S1461145713000667","volume":"17","author":"T Kishi","year":"2014","unstructured":"Kishi T, Iwata N. Meta-analysis of noradrenergic and specific serotonergic antidepressant use in schizophrenia. Int J Neuropsychopharmacol. 2014;17:343\u201354.","journal-title":"Int J Neuropsychopharmacol"},{"key":"2298_CR86","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1111\/acer.14713","volume":"45","author":"ES Kruger","year":"2021","unstructured":"Kruger ES, Serier KN, Pfund RA, McKay JR, Witkiewitz K. Integrative data analysis of self-efficacy in 4 clinical trials for alcohol use disorder. Alcohol: Clin Exp Res. 2021;45:2347\u201356.","journal-title":"Alcohol: Clin Exp Res"},{"key":"2298_CR87","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1001\/jamapsychiatry.2016.4287","volume":"74","author":"IA Cristea","year":"2017","unstructured":"Cristea IA, Gentili C, Cotet CD, Palomba D, Barbui C, Cuijpers P. Efficacy of psychotherapies for borderline personality disorder: a systematic review and meta-analysis. JAMA Psychiatry. 2017;74:319\u201328.","journal-title":"JAMA Psychiatry"},{"key":"2298_CR88","doi-asserted-by":"crossref","first-page":"104857","DOI":"10.1016\/j.neubiorev.2022.104857","volume":"142","author":"AM Monteleone","year":"2022","unstructured":"Monteleone AM, Pellegrino F, Croatto G, Carfagno M, Hilbert A, Treasure J, et al. Treatment of eating disorders: a systematic meta-review of meta-analyses and network meta-analyses. Neurosci Biobehav Rev. 2022;142:104857.","journal-title":"Neurosci Biobehav Rev"},{"key":"2298_CR89","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1111\/j.1600-0447.2008.01213.x","volume":"118","author":"M Lambert","year":"2008","unstructured":"Lambert M, Naber D, Schacht A, Wagner T, Hundemer H, Karow A, et al. Rates and predictors of remission and recovery during 3 years in 392 never-treated patients with schizophrenia. Acta Psychiatr Scand. 2008;118:220\u20139.","journal-title":"Acta Psychiatr Scand"}],"container-title":["Molecular Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02298-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02298-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02298-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,19]],"date-time":"2023-12-19T10:28:10Z","timestamp":1702981690000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41380-023-02298-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":89,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["2298"],"URL":"https:\/\/doi.org\/10.1038\/s41380-023-02298-3","relation":{},"ISSN":["1359-4184","1476-5578"],"issn-type":[{"value":"1359-4184","type":"print"},{"value":"1476-5578","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"22 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2023","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 November 2023","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"CUC has been a consultant and\/or advisor to or has received honoraria from: AbbVie, Acadia, Alkermes, Allergan, Angelini, Aristo, Boehringer-Ingelheim, Cardio Diagnostics, Cerevel, CNX Therapeutics, Compass Pathways, Darnitsa, Denovo, Gedeon Richter, Hikma, Holmusk, IntraCellular Therapies, Janssen\/J&J, Karuna, LB Pharma, Lundbeck, MedAvante-ProPhase, MedInCell, Merck, Mindpax, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Newron, Noven, Novo Nordisk, Otsuka, Pharmabrain, PPD Biotech, Recordati, Relmada, Reviva, Rovi, Seqirus, SK Life Science, Sunovion, Sun Pharma, Supernus, Takeda, Teva, and Viatris. He provided expert testimony for Janssen and Otsuka. He served on a Data Safety Monitoring Board for Compass Pathways, Denovo, Lundbeck, Relmada, Reviva, Rovi, Supernus, and Teva. He has received grant support from Janssen and Takeda. He received royalties from UpToDate and is also a stock option holder of Cardio Diagnostics, Mindpax, LB Pharma and Quantic. CR received the 2020 Lundbeck Foundation Talent Prize. OK-F received honoraria for lectures for Lundbeck Pharma A\/S and consultant work for WCG Clinical. MH has been consultant for or has received honoraria from: H. Lundbeck, The Lundbeck Foundation and Otsuka. MS received honoraria\/has been a consultant for AbbVie, Angelini, Lundbeck, Otsuka. All other authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}},{"value":"Ethical approval for this study was not required.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Authors declare manuscript is an honest, accurate, and transparent account of the study being reported; no important aspects of the study have been omitted; and that any discrepancies from the study as originally planned (and, if relevant, registered) have been explained in published protocol.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}}]}}